Ex-Tox II is a vitamin and mineral blend containing 7 ingredients, designed as an 'Other Combinations' type supplement. This product holds an N+ Score of 69, receiving a C- grade, indicating its status as an average-tier option. A key strength is the inclusion of Folate at a clinically studied dose of 1000 mcg per serving, which research suggests may support various bodily functions. Other notable ingredients include Cilantro Powder (450 mg) and N-Acetyl-L-Cysteine (250 mg). This supplement may be considered by individuals interested in a multi-ingredient formula for general wellness support.
About This Product
Ex-Tox II by Progressive Professional from Progressive Laboratories is a vitamins & minerals supplement containing 7 active ingredients. It has earned an N+ Score of 69/100 (Grade C-).
This product features a fully transparent label with individual ingredient amounts disclosed, and key ingredients are present at clinically effective doses based on peer-reviewed research.
Notable clinical-dose ingredients include Folate.
N+ Score Breakdown
Are key ingredients present at clinically effective doses based on research?
Does the product include all expected ingredients for its supplement category?
Are individual ingredient amounts clearly disclosed without proprietary blends?
Does the formula include a breadth of beneficial compounds from multiple pathways?
Strengths
- +Key ingredients at clinically effective doses
- +Fully transparent label with individual ingredient amounts disclosed
- +Broad ingredient diversity exceeding category norms
- +1 ingredient(s) at clinical dose levels
Weaknesses
- −Missing several expected ingredients for its category
Ingredient Analysis (7 ingredients)
| Ingredient | Amount | Dose Adequacy |
|---|---|---|
| Folate | 1000.000 mcg | Optimal |
| L-Methionine | 50.000 mg | N/A |
| N-Acetyl-L-Cysteine | 250.000 mg | N/A |
| Cilantro, Powder | 450.000 mg | N/A |
| Edetic Acid | 300.000 mg | N/A |
| Fulvic Acid/Humic Acid | 200.000 mg | N/A |
| K-RALA | 100.000 mg | N/A |
Clinical ranges based on NIH ODS Fact Sheets and peer-reviewed research. Status indicates whether the amount meets evidence-based thresholds.